Exelixis Inc (EXEL) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $44.28
• Market Cap: $12.00B
• P/E Ratio: 16.21
• EPS: $2.76
• 52-Week High: $49.62
• 52-Week Low: $32.38

Market Sentiment

Exelixis Inc currently has a Bullish sentiment score of 0.29.

About Exelixis Inc

Exelixis, Inc. is a prominent biotechnology company based in Alameda, California, specializing in the discovery and development of innovative cancer therapies. With a strong commitment to enhancing patient outcomes, Exelixis has established a robust drug pipeline that reflects its strategic focus on oncology. The company leverages advanced research and development capabilities to deliver transformative treatment solutions, positioning itself as a critical player in the competitive biopharmace...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Exelixis Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does EXEL pay dividends?

Exelixis Inc (EXEL) does not currently pay a regular dividend.

What is EXEL's P/E ratio?

Exelixis Inc has a price-to-earnings (P/E) ratio of 16.21.

What is EXEL's market cap?

Exelixis Inc (EXEL) has a market capitalization of $12.00B with a current stock price of $44.28.